Citius Pharmaceuticals, Inc. Operating Lease, Liability, Current
Citius Pharmaceuticals, Inc. (CTXR) had Operating Lease, Liability, Current of $176.17 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $176.17K.
- 2026-03-31: Operating Lease, Liability, Current $171.50K.
- 2025-12-31: Operating Lease, Liability, Current $148.01K.
- 2025-09-30: Operating Lease, Liability, Current $88.35K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $176.17K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $171.50K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $148.01K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $88.35K 10-Q · filed 2026-08-14 |
| 2025-06-30 | $114.69K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $145.10K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $204.57K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $241.55K 10-K · filed 2025-12-23 |
| 2024-06-30 | $235.58K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $229.73K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $224.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $218.38K 10-K · filed 2024-12-27 |
| 2023-06-30 | $212.87K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $207.47K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $202.18K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $196.99K 10-K · filed 2023-12-29 |
| 2022-06-30 | $191.90K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $186.92K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $182.03K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $177.24K 10-K · filed 2022-12-22 |
| 2021-06-30 | $172.54K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $167.94K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $163.42K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $159.00K 10-K · filed 2021-12-15 |
| 2020-06-30 | $154.66K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $150.41K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $146.24K 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |